For dapagliflozin, no tumours were observed in these studies.37 Canagliflozin caused certain types of tumours (for example, renal tubular tumours) in rats, but mechanistic studies revealed that off-target inhibition of SGLT1 in these animals was the underlying mechanism.26 This evidence concerns the gene SLC5A1 and neoplasm.